ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 31 filers reported holding ELEDON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $30,209 | -41.9% | 22,050 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $52,038 | +3.5% | 22,050 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $50,274 | -17.6% | 22,050 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $61,000 | -28.2% | 22,050 | -36.3% | 0.00% | 0.0% |
| Q2 2022 | $85,000 | -37.5% | 34,630 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $136,000 | -11.1% | 34,630 | 0.0% | 0.00% | -25.0% |
| Q4 2021 | $153,000 | -28.5% | 34,630 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $214,000 | -32.5% | 34,630 | -13.5% | 0.01% | -40.0% |
| Q2 2021 | $317,000 | +3.3% | 40,052 | +39.6% | 0.01% | -9.1% |
| Q1 2021 | $307,000 | – | 28,692 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,339,793 | $10,598,000 | 0.89% |
| CM Management, LLC | 75,000 | $593,000 | 0.43% |
| Cormorant Asset Management, LP | 1,415,500 | $11,197,000 | 0.38% |
| BVF INC/IL | 1,113,435 | $8,807,000 | 0.33% |
| Ikarian Capital, LLC | 350,000 | $2,769,000 | 0.22% |
| Woodline Partners LP | 857,445 | $6,782,000 | 0.13% |
| INGALLS & SNYDER LLC | 51,149 | $405,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 853,208 | $6,749,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 40,052 | $317,000 | 0.01% |
| Point72 Asset Management, L.P. | 188,690 | $1,493,000 | 0.01% |